BioSpace News Archive

Business

New Horizons for CellCore Biosciences: Jen Kelly of Fullscript Joins as Vice President of Business Development

CellCore Biosciences has excitedly announced Jen Kelly as their Vice President of Business Development.

December 13, 2023
·
1 min read
Business

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

BioStem Technologies Inc. today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.

December 13, 2023
·
4 min read
Drug Development

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer

Kineta, Inc. announced today the peer-reviewed publication in Frontiers in Immunology of preclinical data highlighting the potential of KVA12123 as a new immunotherapy against poorly immunogenic tumors.

December 13, 2023
·
7 min read
Pharm Country

Inductive Bio Emerges from Stealth, Unveiling an ML Platform to Accelerate Compound Optimization in Drug Discovery

Inductive Bio emerged from stealth today with $4.3M in funding. Their seed round was co-led by Andreessen Horowitz (a16z) Bio + Health and Lux Capital, with participation from Character, Bessemer Venture Partners, Alleycorp, and others.

December 13, 2023
·
5 min read
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

DermaSensor Inc ., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication of a new study 1 in the Journal of Primary Care and Community Health.

December 13, 2023
·
4 min read
Drug Development

Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

Ceapro Inc.(TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) today announced the commencement of patient dosing in its Phase 1-2a study evaluating its flagship product, avenanthramides, for potential applications in managing conditions related to inflammation.

December 13, 2023
·
4 min read
FDA

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

Theratechnologies Inc. today announced that the United States Food and Drug Administration (FDA) has approved the company’s Labelling Prior Approval Supplement to include a 2000-mg intravenous (IV) push loading dose for Trogarzo® (ibalizumab-uiyk).

December 13, 2023
·
7 min read
Genetown

Centessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P. Morgan Healthcare Conference

Centessa Pharmaceuticals plc today announced its participation in the 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Saurabh Saha MD PhD, Chief Executive Officer of Centessa, is scheduled to present at the conference on Wednesday, January 10, 2024, at 4:30 PM PST.

December 13, 2023
·
1 min read
Drug Development

SonALAsense Presents Preliminary Data From Clinical Study in Patients With Deadly Pediatric Brain Tumor

SonALAsense today announced the presentation of positive preliminary data from the ongoing Phase 1/2 SDT-201 study in Diffuse Intrinsic Pontine Glioma (DIPG).

December 13, 2023
·
5 min read
Asahi Kasei develops novel membrane system to dehydrate organic solvents without heat or pressure – Contributing to process optimization in the pharmaceutical industry

Asahi Kasei has developed a novel membrane system for dehydrating organic solvents for pharmaceutical applications without the application of heat or pressure.

December 13, 2023
·
3 min read